Docusign

DOCU-Q

NASDAQ:DOCU

196.47
7.84 (3.84%)
DocuSign, Inc. is an American company headquartered in San Francisco, California that allows organizations to manage electronic agreements. As part of the DocuSign Agreement Cloud, DocuSign offers eSignature, a way to sign electronically on different devices.
More at Wikipedia

Analysis and Opinions about DOCU-Q

Signal
Opinion
Expert
Chart
BUY
BUY
May 3, 2021
It is oddly stalled, flat-lining. It seems the business of making documents happen remotely should continue to do well as we recover.
Show full opinionHide full opinion
Docusign (DOCU-Q)
May 3, 2021
It is oddly stalled, flat-lining. It seems the business of making documents happen remotely should continue to do well as we recover.
Brendan Caldwell
Price
$214.450
Owned
Unknown
DON'T BUY
DON'T BUY
March 29, 2021
It's down a lot from its high, and is part of the stay-at-home trade, which is way out of fashion now. He needs to see a good quarter to prove DOC isn't just a stay at home.
Show full opinionHide full opinion
Docusign (DOCU-Q)
March 29, 2021
It's down a lot from its high, and is part of the stay-at-home trade, which is way out of fashion now. He needs to see a good quarter to prove DOC isn't just a stay at home.
Jim Cramer - Mad Money
Price
$197.970
Owned
Unknown
BUY WEAKNESS
BUY WEAKNESS
March 16, 2021
It's done incredibly well during the pandemic as e-signatures blossomed. Growth will continue, but that rate may slow this year. Also, the valuation is too high now. It's a growth-momentum name.
Show full opinionHide full opinion
Docusign (DOCU-Q)
March 16, 2021
It's done incredibly well during the pandemic as e-signatures blossomed. Growth will continue, but that rate may slow this year. Also, the valuation is too high now. It's a growth-momentum name.
Christine Poole
Price
$211.155
Owned
Unknown
TOP PICK
TOP PICK
January 7, 2021
Stockchase Research Editor: Michael O'Reilly As the roll out of vaccines is falling behind projections in North America, the prospect of continued growth in electronic document signings could likely continue, contrary to several analyst opinions. Pipe Sandler has taken this view and has upgraded their outlook on the stock to $300. We would buy this with a stop-loss at $190, looking to achieve $285 -- about 20% upside. (Analysts’ price target is $275.39)
Show full opinionHide full opinion
Docusign (DOCU-Q)
January 7, 2021
Stockchase Research Editor: Michael O'Reilly As the roll out of vaccines is falling behind projections in North America, the prospect of continued growth in electronic document signings could likely continue, contrary to several analyst opinions. Pipe Sandler has taken this view and has upgraded their outlook on the stock to $300. We would buy this with a stop-loss at $190, looking to achieve $285 -- about 20% upside. (Analysts’ price target is $275.39)
Stockchase Research
Price
$239.030
Owned
_N/A
COMMENT
COMMENT
September 30, 2020
The stock sold off after running up and slid along with all tech stocks this past month. It's pulled back 25% from its highs, but still nearly triple YTD. It's not cheap, but it has a new AI product that looks promising. Is it time to buy on weakness?
Show full opinionHide full opinion
Docusign (DOCU-Q)
September 30, 2020
The stock sold off after running up and slid along with all tech stocks this past month. It's pulled back 25% from its highs, but still nearly triple YTD. It's not cheap, but it has a new AI product that looks promising. Is it time to buy on weakness?
SELL
SELL
July 24, 2020
A game changer stock. They use it in their office for official document signing. Revenues have increased sharply, but the share price is now 25 times sales -- very expensive. You have to consider what the future length of runway looks like. He would caution against buying into high multiple stocks at the moment. He would be a seller on this right now in the event personal tax rates increase in the future.
Show full opinionHide full opinion
Docusign (DOCU-Q)
July 24, 2020
A game changer stock. They use it in their office for official document signing. Revenues have increased sharply, but the share price is now 25 times sales -- very expensive. You have to consider what the future length of runway looks like. He would caution against buying into high multiple stocks at the moment. He would be a seller on this right now in the event personal tax rates increase in the future.
BUY
BUY
July 21, 2020
They make e-signatures and contract management. DOCU has benefitted from this stay-at-home pandemic. They're moving into managing entire documents which will lead to decent growth and better pricing on their software. The U.S. is moving away from paper in business and more into digital, which is a tailwind.
Show full opinionHide full opinion
Docusign (DOCU-Q)
July 21, 2020
They make e-signatures and contract management. DOCU has benefitted from this stay-at-home pandemic. They're moving into managing entire documents which will lead to decent growth and better pricing on their software. The U.S. is moving away from paper in business and more into digital, which is a tailwind.
Paul Harris, CFA
Price
$0.000
Owned
Unknown
DON'T BUY
DON'T BUY
June 9, 2020

Tech, work from home stocks have run up and DOCU is getting rich with a high valuation. Look at MSFT instead.

Show full opinionHide full opinion
Docusign (DOCU-Q)
June 9, 2020

Tech, work from home stocks have run up and DOCU is getting rich with a high valuation. Look at MSFT instead.

Stan Wong
Price
$0.000
Owned
No
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Docusign(DOCU-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 3

Total Signals / Votes : 6

Stockchase rating for Docusign is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Docusign(DOCU-Q) Frequently Asked Questions

What is Docusign stock symbol?

Docusign is a American stock, trading under the symbol DOCU-Q on the NASDAQ (DOCU). It is usually referred to as NASDAQ:DOCU or DOCU-Q

Is Docusign a buy or a sell?

In the last year, 6 stock analysts published opinions about DOCU-Q. 3 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Docusign.

Is Docusign a good investment or a top pick?

Docusign was recommended as a Top Pick by Brendan Caldwell on 2021-05-03. Read the latest stock experts ratings for Docusign.

Why is Docusign stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Docusign worth watching?

6 stock analysts on Stockchase covered Docusign In the last year. It is a trending stock that is worth watching.

What is Docusign stock price?

On 2021-05-05, Docusign (DOCU-Q) stock closed at a price of $196.47.